Cargando…
4 in 1: Antibody‐free protocol for isolating the main hepatic cells from healthy and cirrhotic single rat livers
Liver cells isolated from pre‐clinical models are essential tools for studying liver (patho)physiology, and also for screening new therapeutic options. We aimed at developing a new antibody‐free isolation method able to obtain the four main hepatic cell types (hepatocytes, liver sinusoidal endotheli...
Autores principales: | Fernández‐Iglesias, Anabel, Ortega‐Ribera, Martí, Guixé‐Muntet, Sergi, Gracia‐Sancho, Jordi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349241/ https://www.ncbi.nlm.nih.gov/pubmed/30417530 http://dx.doi.org/10.1111/jcmm.13988 |
Ejemplares similares
-
Advances in therapeutic options for portal
hypertension
por: Vilaseca, Marina, et al.
Publicado: (2018) -
Emricasan Ameliorates Portal Hypertension and Liver Fibrosis in Cirrhotic Rats Through a Hepatocyte‐Mediated Paracrine Mechanism
por: Gracia‐Sancho, Jordi, et al.
Publicado: (2019) -
The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer
por: Gibert-Ramos, Albert, et al.
Publicado: (2021) -
Liraglutide improves liver microvascular dysfunction in cirrhosis: Evidence from translational studies
por: de Mesquita, Fernanda Cristina, et al.
Publicado: (2017) -
Regression of portal hypertension: underlying mechanisms and therapeutic strategies
por: Selicean, Sonia, et al.
Publicado: (2021)